Evera MRI SureScan ICD System
FDA APPROVED: September 2015
FIRST APPEARANCE IN CHATTANOOGA: October 2015
NOTES: With the newest generation of ICDs, patients can undergo an MRI without complications – eliminating any need to choose between diagnostic imaging and treating a dangerous heart rhythm.
WHY YOU MIGHT NEED AN ICD
ICDs treat certain types of arrhythmia, which is any irregularity in your heart’s rhythm. You may need an ICD if you have a dangerously fast heartbeat (ventricular tachycardia), a chaotic heartbeat that makes it so your heart can’t supply enough blood to the rest of your body (ventricular fibrillation), or if you have a known risk of sudden cardiac arrest.
HOW ICDS WORK
If you have a life-threatening arrhythmia or a known risk of cardiac arrest, a cardiologist will implant a battery-powered ICD beneath your skin under your collarbone. Two leads, or wires with electrodes, will stretch from the ICD to the heart to keep track of your heart rate. If the device detects an abnormal rhythm, it will send small electrical pulses to your heart to restore a normal rhythm. If these don’t work, it will send a low energy shock followed by a high energy shock.
Until now if you needed an MRI but had an ICD, you were out of luck. The MRI would heat up the ICD’s wires, causing the wires to also heat up the heart muscle. Many patients needing an ICD have even forfeited the opportunity to implant one in order to continue imaging for a different condition, such as a back or joint condition. The incompatibility of ICDs and MRI also presented an obstacle to physicians looking to quickly and efficiently diagnose a stroke.
HOW THE EVERA ICD WORKS
The Evera MRI SureScan ICD System allows patients to safely undergo full-body MRIs, thanks to several design and material modifications. The new ICD will not overheat in response to the MRI environment, and its hardware components ensure high energy fields will not damage circuits.
An Expert Weighs In
This new ICD is just as good as a standard ICD, if not better, and it allows you to receive an MRI. In no way is it inferior to previous models, and for patients with overlapping diseases, it has the potential to be revolutionary. It will expedite care for many stroke patients because they will now be able to receive an MRI right when they walk through the door.
Christian Allan, MD,
SYNERGYBioabsorbable Polymer Drug-Eluting Stent System
MANUFACTURER: Boston Scientific
FDA APPROVED: October 2015
FIRST APPEARANCE IN CHATTANOOGA: November 2015
NOTES: The newest generation of stents promises a faster recovery time and lower risk of complications. Its defining feature? An absorbable polymer coating.
WHY YOU MIGHT NEED A STENT Stents are used to treat coronary artery disease (CAD), the most common kind of heart disease and the number one cause of death for both men and women in the U.S. In CAD, the coronary arteries become clogged with waxy cholesterol deposits called plaque. As plaque continues to build up, the arteries delivering blood to the heart muscle harden and narrow. Eventually, this narrowing can lead to chest pain (angina) and heart attack.
HOW STENTS WORK Stents are a standard treatment for heart attack in progress or unstable angina, a serious form of chest pain requiring emergency treatment. During a procedure called an angioplasty, a cardiologist uses a catheter to insert a stent into the clogged artery. The stent is then left in the artery permanently to hold it open and improve blood flow.
FORMER STENTS Since the early 2000s, cardiologists have used drug-eluting stents, which release drugs to prevent re-narrowing of the artery. Drug-eluting stents are significantly better than their predecessors, and yet a polymer coating remains on the stent after the drug is delivered. Long-term exposure to this polymer can cause inflammation, which delays healing and has been associated with the formation of blood clots and the reappearance of plaque.
HOW SYNERGY WORKS Unlike standard drug-eluting stents, Boston Scientific’s SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) has a bioabsorbable polymer coating. This means that after the drugs are fully released in the arteries – which takes three months – the stent’s polymer coating is also absorbed by the body, leaving only the stent itself behind.
An Expert Weighs In
The goal of newer stents is to decrease any chance of needing a second procedure. This stent not only improves healing time with its absorbable polymer, but it’s smaller and easier to place in a patient. It’s a good option for any patient who needs a stent, but particularly those who have a high risk of arteries renarrowing. Right now, this new stent accounts for about 50% of all stents we place at Erlanger.
John V. Golding, MD, FACC, Cardiologist, UT Erlanger Cardiology, Erlanger Health System